Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Policy

    Policy - Page 18

    Refix Ceiling Price of Tetanus Toxoid Vaccine: DoP directs NPPA

    Refix Ceiling Price of Tetanus Toxoid Vaccine: DoP directs NPPA

    Meghna A Singhania30 March 2019 2:03 PM IST
    New Delhi: The Department of Pharmaceuticals (DoP) has accepted the review petition of Biological E Limited against price fixation of Tetanus Toxoid...
    JnJ Faulty Hip Implants: 7 more patients found fit for compensation

    JnJ Faulty Hip Implants: 7 more patients found fit for compensation

    Meghna A Singhania30 March 2019 1:15 PM IST
    Mumbai: Several patients who claim to be suffering due to faulty hip implants manufactured by Johnson and Johnson (JnJ) have been claiming...
    FDC Rationality: Now 6 months accelerated stability study data to be submitted, directs DCGI

    FDC Rationality: Now 6 months accelerated stability study data to be submitted, directs DCGI

    Meghna A Singhania27 March 2019 4:48 PM IST
    New Delhi: Manufacturers of Fixed Dose Combinations drugs ( FDC drugs) which have declared rational and approved by Drugs Controller General India...
    Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO

    Manufacturers of SGLT2 inhibitor Drugs to have to INCLUDE safety WARNING in package: CDSCO

    Farhat Nasim26 March 2019 1:28 PM IST
    New Delhi: Paying heed to the safety updates of Sodium-Glucose Cotransporter-2 (SGLT2) including medicines such as Canagliflozin, Dapagliflozin,...
    Government notifies Drugs and Clinical Trial Rules 2019

    Government notifies Drugs and Clinical Trial Rules 2019

    Meghna A Singhania26 March 2019 9:31 AM IST
    The new rules will ensure patient safety, as they would be enlisted for trials with informed consent. The ethics committee will monitor the trials and...
    FDA approves new device for treating moderate to severe chronic heart failure in patients

    FDA approves new device for treating moderate to severe chronic heart failure in patients

    Farhat Nasim25 March 2019 11:51 AM IST
    U.S: The U.S. Food and Drug Administration recently approved the Optimizer Smart system for treating patients with chronic, moderate-to-severe heart...
    Interim Relief: Delhi High Court stays ban on e-cigarettes,Vapes,E-Sheesha till May 17, 2019

    Interim Relief: Delhi High Court stays ban on e-cigarettes,Vapes,E-Sheesha till May 17, 2019

    Meghna A Singhania24 March 2019 11:00 AM IST
    Delhi High Court observed that Electronic Nicotine Delivery Systems(ENDS) including e cigarettes cannot be regarded as 'drugs'. New Delhi: Granting...
    Stop promotion of tobacco brands in Filmfare Awards: Delhi Government Official to Centre

    Stop promotion of tobacco brands in Filmfare Awards: Delhi Government Official to Centre

    Meghna A Singhania23 March 2019 9:30 AM IST
    Additional Director in Delhi Health Department Dr S K Arora, who was earlier heading Delhi State Tobacco Control cell, wrote the letters in his...
    NPPA fixes retail price of Certain Hard Gelatin Capsules; Check Details

    NPPA fixes retail price of Certain Hard Gelatin Capsules; Check Details

    Meghna A Singhania22 March 2019 3:25 PM IST
    New Delhi: Through a recent notice, the drug price regulator National Pharmaceutical Pricing Authority (NPPA) has fixed the retail price of hard...
    Union Health Ministry blocking Juul e cigarettes from coming into country: Report

    Union Health Ministry blocking Juul e cigarettes from coming into country: Report

    Meghna A Singhania18 March 2019 12:42 PM IST
    "Novel products such as 'Juul' are harmful and addictive and could potentially undermine our tobacco control efforts," Health Secretary Preeti Sudan...
    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Setback to Sun Pharma: NPPA refuses to give relief of price cap exemption for Gemcitabine

    Meghna A Singhania17 March 2019 1:33 PM IST
    New Delhi: In a major setback to Sun Pharmaceuticals Ltd, the drug price regulator the National Pharmaceutical Pricing Authority(NPPA) has refused to...
    NPPA revises MRP of another 463 anti cancer medicines; Check Details

    NPPA revises MRP of another 463 anti cancer medicines; Check Details

    Meghna A Singhania13 March 2019 4:39 PM IST
    NEW DELHI: Through a recent official release, National Pharmaceutical Pricing Authority (NPPA) has informed about the revision in the maximum retail...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Shipment of  antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Shipment of antimalarial drug to US is likely to start next week: Indian Pharmaceutical Alliance

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Top priority on Delivery of Medicines through Speed Post: Minister

    Top priority on Delivery of Medicines through Speed Post: Minister

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Lupin gets USFDA EIR for Nagpur Facility

    Lupin gets USFDA EIR for Nagpur Facility

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok